GENE EXPRESSION DURING OSTEOCLAST DIFFERENTIATION

破骨细胞分化过程中的基因表达

基本信息

项目摘要

The osteoclast is a unique cell which arises from a hematopoietic precursor it shares with cells of the granulocyte and monocyte lineages. When activated, it becomes polarized, forms a ruffled border and causes release of bone mineral and proteolytic degradation of the bone matrix. The goal of this project is to elucidate changes in expression of specific genes during osteolysis and during differentiation of the precursors. We plan to quantify changes in the expression of two classes of specific genes: a) those directly associated with osteolysis (such as carbonic anhydrase II, the lysosomal protease cathepsin 0, the ruffled border proton pump, and superoxide dismutase) and b) hormonal responses of these to regulatory factors such as calcitonin, vitamin A, phorbol myristate acetate, 1,25 dihydroxyvitamin D-3 and tumor necrosis factor. We will also plan to determine the functional importance of these gene products by manipulating the phenotype of cultured avian osteoclasts. This will be done by the introduction of DNA constructs which express sense or antisense RNA, thereby raising or lowering the levels of specific cellular marker proteins independent of hormonal regulation of the cells. Two model systems will be used for these studies. The human promyelocytic leukemic cell line HL-60 shares phenotypic features with early precursor cells in the osteoclast lineage. This cell line will be used as a representative of an early osteoclast progenitor. As a model for mature osteoclasts, we will use isolated chicken osteoclasts. These cells, unlike mammalian osteoclasts, are available in sufficient quantities to allow application of the techniques of molecular biology.
破骨细胞是一种由造血前体产生的独特细胞

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN M CHIRGWIN其他文献

JOHN M CHIRGWIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN M CHIRGWIN', 18)}}的其他基金

Manipulating the N-end Rule Protein Degradation Pathway to Build Bone and Decrease Tumor Growth in Multiple Myeloma Bone Disease
操纵 N 端规则蛋白降解途径来构建骨并减少多发性骨髓瘤骨病中的肿瘤生长
  • 批准号:
    10582710
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
A Novel Agent to Suppress Tumor Growth in Bone, Prevent Cachectic Muscle Loss and Preserve Skeletal Integrity
一种抑制骨肿瘤生长、防止恶病质肌肉损失并保持骨骼完整性的新型药物
  • 批准号:
    10158431
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
A Novel Agent to Suppress Tumor Growth in Bone, Prevent Cachectic Muscle Loss and Preserve Skeletal Integrity
一种抑制骨肿瘤生长、防止恶病质肌肉损失并保持骨骼完整性的新型药物
  • 批准号:
    10454796
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
A Novel Agent to Suppress Tumor Growth in Bone, Prevent Cachectic Muscle Loss and Preserve Skeletal Integrity
一种抑制骨肿瘤生长、防止恶病质肌肉损失并保持骨骼完整性的新型药物
  • 批准号:
    9912632
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Role of Osteocytes in Myeloma Bone Disease
骨细胞在骨髓瘤骨病中的作用
  • 批准号:
    8736266
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
Role of Osteocytes in Myeloma Bone Disease
骨细胞在骨髓瘤骨病中的作用
  • 批准号:
    9336849
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
Role of Osteocytes in Myeloma Bone Disease
骨细胞在骨髓瘤骨病中的作用
  • 批准号:
    8922796
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
GENE EXPRESSION DURING OSTEOCLAST DIFFERENTIATION
破骨细胞分化过程中的基因表达
  • 批准号:
    3804511
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
GENE EXPRESSION DURING OSTEOCLAST DIFFERENTIATION
破骨细胞分化过程中的基因表达
  • 批准号:
    3792168
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Development of a method for preserving transplanted lung function using Gapmer-type antisense nucleic acid
开发利用Gapmer型反义核酸保存移植肺功能的方法
  • 批准号:
    22K09003
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Myostatin antisense nucleic acid therapy for rhabdomyosarcoma
肌肉生长抑制素反义核酸治疗横纹肌肉瘤
  • 批准号:
    21K07762
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Suppression of PHOX2B (+7Ala mutant) expression by antisense nucleic acid
反义核酸抑制 PHOX2B(7Ala 突变体)表达
  • 批准号:
    20K16927
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Pathogenesis and Antisense nucleic acid, glycosylation supplementation, and AAV therapy development forFukuyama muscular dystrophy and related diseases
福山性肌营养不良症及相关疾病的发病机制和反义核酸、糖基化补充以及 AAV 疗法的开发
  • 批准号:
    20H00526
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Synthesis of antisense nucleic acid incorporating cyclic sulfonamide backbone
掺入环状磺酰胺主链的反义核酸的合成
  • 批准号:
    20K21245
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Antisense nucleic acid splice correction therapy for Duchenne muscular dystrophy and related disorders
杜氏肌营养不良症及相关疾病的反义核酸剪接校正疗法
  • 批准号:
    G0900887/1
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
    Research Grant
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID "2'-PHOSPHORYLATED RNAS" -DIRECTED TOWARD ITS BASIC STRUCTURAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
反义核酸新材料“2-磷酸化RNAS”的化学合成-针对其基础结构研究和HIV病毒表达调控-
  • 批准号:
    05558090
  • 财政年份:
    1993
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID"2"PHOSTHORYLATEDRNAS" DIRETED TOWARD IIS BASIC STRUCTRAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
针对 IIS 基础结构研究和 HIV 病毒表达调控的反义核酸新材料“2”磷酸化 RNA 的化学合成-
  • 批准号:
    04453031
  • 财政年份:
    1992
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了